SIR Capital Management’s Core Laboratories CLB Stock Holding History

SIR Capital Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-13,200	Closed	-$497K	–	35
2019 Q4	$497K	Sell	13,200 -49,704	-79%	-$2.23M	0.09%	38
2019 Q3	$2.93M	Sell	62,904 -62,096	-50%	-$2.89M	0.72%	34
2019 Q2	$6.54M	Buy	+125,000	New	+$7.33M	1.14%	31
2017 Q3	–	Sell	-221,037	Closed	-$22.4M	–	53
2017 Q2	$22.4M	Buy	221,037 +176,837	+400%	+$19.1M	3.36%	9
2017 Q1	$5.11M	Buy	+44,200	New	+$5.14M	0.68%	42

Other funds holding CLB

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

SIR Capital Management's CLB Position: Q1 2020 in Review

SIR Capital Management sold out of Core Laboratories (CLB) in Q1 2020, closing a stake of 13,200 shares — an estimated $497K sold.

SIR Capital Management first reported a position in CLB in Q1 2017 and held it in 5 quarters. The position peaked at $22.4M in Q2 2017. 207 funds tracked by Wall St. Rank hold CLB as of Q1 2020.

SIR Capital Management reported no remaining Core Laboratories position as of Q1 2020 after selling out during the quarter.
SIR Capital Management sold 13,200 Core Laboratories shares in Q1 2020, an estimated $497K.
SIR Capital Management first reported a position in Core Laboratories in Q1 2017 and held it in 5 quarters.
SIR Capital Management's Core Laboratories position peaked at $22.4M in Q2 2017.
207 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2020.

Based on SIR Capital Management's 13F filing for Q1 2020, filed 15 May 2020.